Skip to main content

Table 4 Review of prognostic factors for OS and/or EFS in previous studies by univariate and multivariate analysis

From: The extremity localized classic osteosarcomas have better survival than the axial non-classics

 

Vasquez et al. [9]

Whelan et al. [2]

Pakos et al. [15]

Janeway et al. [17]

Pruksakorn et al. [18]

Duchman et al. [28]

Min et al. [8]

Faisham et al. [27]

Petrilli et al. [13]

n = 73

n = 1067

n = 2680

n = 1054

n = 144

n = 2949

n = 333

n = 163

n = 209

OS + EFS

OS + PFS

OS

OS + EFS

OS

OS

OS

OS

OS + EFS

UVA

MVA

UVA

MVA

UVA

MVA

UVA

MVA

UVA

MVA

UVA

MVA

UVA

MVA

UVA

MVA

UVA

MVA

Gender

ns

s

s

ns

ns

ns

s

s

s

s

s

ns

Age

ns

ns

s

s

s

s

s

ns

s

s

ns

s

s

Tumor site

ns

s

s

s

s

s

s

s

s

s

s

ns

Tumor size

s

ns

ns

s

s

s

ns

Symptom duration

ns

Primary metastasis

s

s

s

s

s

s

s

s

s

s

s

s

s

s

Serum ALP

s

s

s

s

Serum LDH

ns

Surgery type

s

ns

s

s

ns

s

  1. s significant, ns not significant, OS overall survival, EFS event-free survival, PFS progression-free survival, UVA univariate analysis, MVA multivariate analysis, ALP alkaline phosphatase, LDH lactate dehydrogenase